Windtree Therapeutics, Inc. (NASDAQ:WINT – Get Free Report)’s stock price traded up 3.7% on Wednesday . The company traded as high as $3.45 and last traded at $3.32. 1,645,067 shares changed hands during trading, an increase of 238% from the average session volume of 486,865 shares. The stock had previously closed at $3.20.
Windtree Therapeutics Price Performance
The stock has a market cap of $1.97 million, a P/E ratio of -0.09 and a beta of 0.58. The stock’s 50-day moving average is $6.96 and its two-hundred day moving average is $5.66.
Windtree Therapeutics (NASDAQ:WINT – Get Free Report) last released its quarterly earnings data on Monday, August 19th. The company reported ($20.91) EPS for the quarter, missing the consensus estimate of ($8.11) by ($12.80). On average, analysts anticipate that Windtree Therapeutics, Inc. will post -2.38 EPS for the current fiscal year.
Windtree Therapeutics Company Profile
Windtree Therapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company's lead product is istaroxime which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock.
Read More
- Five stocks we like better than Windtree Therapeutics
- How to Calculate Stock Profit
- How Much Can You Make in Stocks in One Month?
- Best Stocks Under $5.00
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to Invest in Blue Chip Stocks
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
